IFF Stock Recent News

PARIS--(BUSINESS WIRE)--IFF (NYSE: IFF) unveils its Science of Performance program, a comprehensive, science-driven suite that enhances fragrance creation by increasing efficiency and precision to manage scent intensity and control malodors. The program combines decades of measured data enhanced by proprietary AI capabilities, along with advanced sensory, technical, consumer and market expertise in various end-user applications. "Science of Performance is a unique approach to scent performance.

NEW YORK--(BUSINESS WIRE)--IFF (NYSE:IFF) and Kemira announced the formation of Alpha Bio, a joint venture aimed at commercial-scale production of renewable biobased materials. With an investment of approximately €130 million, the Alpha Bio facility will start production in late 2027, converting up to 44,000 MT of plant sugars to bioproducts, including high-performance biopolymers for use in various applications, such as home and personal care and industrial solutions. Alpha Bio's production wi.

TOKYO--(BUSINESS WIRE)--IFF (NYSE:IFF) Pharma Solutions will showcase its cutting-edge excipient technologies at CPHI Japan 2025. The IFF Pharma Solutions team will highlight its innovations in oral disintegrating tablets (ODTs), controlled-release formulations, and novel complex formulations at booth 5K-21, Tokyo Big Sight East Halls 4-6, April 9-11. “IFF Pharma Solutions is committed to redefining drug delivery through material science innovation,” said Frank Zhao, commercial leader, IFF Phar.

IFF is likely to gain from demand for flavors & fragrances amid high costs and lower Food Ingredients business volumes.

International Flavors (IFF) reported earnings 30 days ago. What's next for the stock?

NEW YORK--(BUSINESS WIRE)---- $IFF--IFF (NYSE: IFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 11, 2025 to shareholders of record as of March 21, 2025. Welcome to IFF At IFF (NYSE: IFF), we make joy through science, creativity and heart. As the global leader in flavors, fragrances, food ingredients, health and biosciences, we deliver groundbreaking, sustainable innovations that elevate everyday products—ad.

NEW YORK--(BUSINESS WIRE)--IFF (NYSE: IFF) announced changes to its executive leadership team, aligned with the Company's external reporting structure. After 21 years of dedicated service to IFF, Simon Herriott, president of Health and Biosciences, will step down. Effective March 1, Leticia Gonçalves, ADM's president of precision fermentation and ADM Ventures, will join IFF as president of Health and Biosciences. “Since 2019, Simon has driven growth and operational effectiveness through innovat.

International Flavors & Fragrances Inc. (NYSE:IFF ) Q4 2024 Earnings Call Transcript February 19, 2025 9:00 AM ET Company Participants Michael Bender - Director, Investor Relations Erik Fyrwald - Chief Executive Officer Michael DeVeau - EVP, Chief Financial Officer Conference Call Participants Kristen Owen - Oppenheimer Josh Spector - UBS Nicola Tang - BNP Paribas Emily Fusco - Deutsche Bank Eric Zhang - Citi Lisa Neve - Morgan Stanley Steve Byrne - Bank of America John Roberts - Mizuho Mike Sison - Wells Fargo Matt Hettwer - Vertical Research Partners Mark Astrachan - Stifel Kate Grafstein - Barclays Silke Kueck - JPMorgan Dan Rizzo - Jefferies Artem Chubarov - Redburn Atlantic Harris Fein - Wolfe Research Operator Good morning. At this time, I would like to welcome everyone to the IFF's Fourth Quarter and Full Year 2024 Earnings Conference Call.

IFF Q4 results reflect the impacts of growth across all segments and productivity gains.

The headline numbers for International Flavors (IFF) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.